Belgium suspends the use of the Johnson & Johnson COVID-19 vaccine for people under the age of 41 following the death of a woman who had received the vaccine last week and who was showing "serious thrombosis and reduced blood platelets".
Belgium suspends the use of the Johnson & Johnson COVID-19 vaccine for people under age 41 following a death of a woman who had received the vaccine last week and showing "serious thrombosis and reduced blood platelets".
Belgium suspends the use of the Johnson & Johnson COVID-19 vaccine for people under theage of41 following the death of a woman who had received the vaccine last week andwhowas showing "serious thrombosis and reduced blood platelets".
